Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aducanumab
2
×
alzheimer's disease
2
×
biogen
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
accent therapeutics
adalimumab (humira)
aduro biotech
affordable care act
alez azar
What
bio
new
roundup
activity
approval
approvals
biogen
biogen’s
biopharmaceutical
clamped
companies
convo
covid
delays
developing
drug
earlier
economic
failures
fast
fda
including
ipo
isn’t
littered
lot
medicines
nash
news
oric’s
price
remains
road
showing
spread
strategy
talk
testing
work
Language
unset
Current search:
aducanumab
×
biotech
×
" alzheimer's disease "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More